Aethlon Medical, Inc. (OTCMKTS:AEMD) Hesitates Around 25 Cents

[[tagnumber 0]][[tagnumber 1]]Aethlon Medical, Inc. (OTCMKTS:AEMD) has received major investor interest recently, due to the ebola craze and the fact that the company is one of the rare cases in which it has an actual product that might help with the treatment of the disease.[[tagnumber 2]] [[tagnumber 0]] [[tagnumber 2]] [[tagnumber 0]]As we mentioned in our previous articles, [[tagnumber 6]]AEMD’s[[tagnumber 7]] Hemopurifier® was reported to be used on a Ugandan doctor who contracted the disease while working in Sierra Leone and is currently being treated at the Frankfurt University Hospital in Germany and we were all anticipating the results.[[tagnumber 2]] [[tagnumber 0]] [[tagnumber 2]] [[tagnumber 0]]Last Thursday, the company made an announcement that the virus is now undetectable in the patient that is being treated with the Hemopurifier®. The Wall Street Journal also reported on that fact, but didn’t mention [[tagnumber 6]]AEMD’s [[tagnumber 7]]involvement in the treatment.[[tagnumber 2]] [[tagnumber 0]] [[tagnumber 2]] [[tagnumber 0]]The market reacted immediately and [[tagnumber 6]]AEMD [[tagnumber 7]]gained 9.18% during the day’s trading. The total amount of shares also showed increased investor attention as the 4.83 million that changed their owners generated $1.23 million in daily dollar volume.[[tagnumber 2]] [[tagnumber 0]] [[tagnumber 2]] [[tagnumber 0]]Unfortunately, the hype didn’t last and the ticker slid 3.63% in the final session before the weekend, closing at $0.2419 per share with a trade value of $651 thousand after gapping up at $0.26.[[tagnumber 2]] [[tagnumber 0]] [[tagnumber 2]] [[tagnumber 0]]Still, despite all the craze surrounding the companies that have, or are in the works of, treatments for ebola we can’t expect this to go forever. After all, the cases of death from ebola in recent months is 5000, or 100 times less that the people that die from the common flu each year and as someone put it – “[[tagnumber 28]]the most infectious thing about it is the media hype around it[[tagnumber 29]]”.[[tagnumber 2]] [[tagnumber 0]] [[tagnumber 2]] [[tagnumber 0]]In any case, you should always remember to do your due diligence and weigh out the risks that come with every investment.[[tagnumber 2]]